PHIL 2130 Chapter Notes - Chapter 7.4: Decongestant, Nebulizer, Nostril
6 May 2020
School
Department
Course
Professor
Document Summary
Nasal, inhalant and transdermal dosage forms language of practice. Nasal preparations: drops (solutions) and sprays (solutions and suspensions) Prolonged use of topical nasal decongestant can lead to rebound congestion (don"t use for more than 3-5 days. Gently blow nose; tilt head slightly forward or back [ps] Close one nostril and apply medication to other nostril. Prime for first time use or if not used for a period of time (product specific [ps]) Spray # dose(s) or use # spray(s) into location . Patient must be able to coordinate device activation with breathing. Difficult to ensure total dose reaches the lungs (poor dose accuracy) Devices (nebulizers, inhalers) must be clean since they can be a source of infection. Instruct on: -verb and method of administration of device (proper technique) Number of daily doses and frequency of administration. Auxiliary labels for bronchial inhalant devices: shake well for mdi only. A device that uses inhalant solutions (contains water, medicinal ingredient and preservative)
